Krebs Biochemicals & Industries Ltd
Krebs Biochemicals & Industries Ltd (KREBSBIO)

Krebs Biochemicals & Industries Ltd (KREBSBIO)


Key Stats

Day's Price Range
52-Week Price Range
1 Month Return-16.89 %
3 Month Return5.64 %
1 Year Return-38.3 %

Company Financials

  • Annual
Value in ₹ crore

Peer Comparsion

Rank 299
Rank 303
Rank 326
Dividend Yield
Rank 177
Rank 455
Price To Book Ratio
Rank 262
Debt To Asset
Rank 316

Company Information

Krebs Biochemicals Industries LtdKBILFormerly Krebs Biochemicals Ltd promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical IngredientsAPI through Fermentation process one among very few in the world to do the same.KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. KBIL since inception has adopted global agenda for its growth by focusing on its specific area of expetise Fermentation Technology. During 200102 the company has successfully launched Vitamin CI P Grade through Fermentation Process.The company has also received ISO 9002 Certification for Unit I at Nellore from Yarsley International Certifications Services accredited by United Kingdom Accreditation Services. The company is now producing and marketing LovastatinSimvastatin and VitaminC. The company is now in the process of installing a cogeneration power plant at UnitII. As a step in the direction of backward integration and to capitalise on cogeneration and Ethanol manufacturing the company has successfully bidded and acquired the Nannapaneni Venkatrao Cooperative Sugars Ltd located at Jampani in Guntur District of Andhra Pradesh from the Andhra Pradesh Government in Dec 28 2003.
OrganisationKrebs Biochemicals & Industries Ltd